Leerink Partnrs Issues Negative Outlook for A Earnings

Agilent Technologies, Inc. (NYSE:A) – Leerink Partnrs dropped their Q1 2025 earnings per share estimates for Agilent Technologies in a note issued to investors on Tuesday, November 26th. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will post earnings per share of $1.28 for the quarter, down from their prior estimate of $1.36. The consensus estimate for Agilent Technologies’ current full-year earnings is $5.72 per share. Leerink Partnrs also issued estimates for Agilent Technologies’ Q2 2025 earnings at $1.33 EPS, Q3 2025 earnings at $1.41 EPS, Q4 2025 earnings at $1.55 EPS, FY2025 earnings at $5.57 EPS and FY2026 earnings at $6.10 EPS.

A has been the subject of a number of other reports. Sanford C. Bernstein lowered their target price on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research note on Tuesday. StockNews.com cut Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Tuesday. Wells Fargo & Company initiated coverage on Agilent Technologies in a research report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 price target for the company. Bank of America upped their price target on Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $151.00 price target on shares of Agilent Technologies in a research report on Monday, August 26th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $143.40.

Agilent Technologies Stock Performance

A stock opened at $138.11 on Wednesday. Agilent Technologies has a 1-year low of $124.10 and a 1-year high of $155.35. The business’s 50-day moving average price is $137.72 and its two-hundred day moving average price is $137.43. The firm has a market cap of $39.68 billion, a PE ratio of 31.25, a P/E/G ratio of 5.91 and a beta of 1.07. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36.

Institutional Trading of Agilent Technologies

Large investors have recently bought and sold shares of the business. Crewe Advisors LLC boosted its stake in shares of Agilent Technologies by 114.8% during the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 101 shares in the last quarter. Livelsberger Financial Advisory acquired a new stake in shares of Agilent Technologies during the third quarter valued at about $28,000. Ridgewood Investments LLC acquired a new stake in shares of Agilent Technologies during the second quarter valued at about $29,000. Ashton Thomas Securities LLC acquired a new stake in shares of Agilent Technologies during the third quarter valued at about $31,000. Finally, Fortitude Family Office LLC boosted its stake in shares of Agilent Technologies by 68.3% during the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after purchasing an additional 95 shares in the last quarter.

Insider Buying and Selling

In related news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares in the company, valued at approximately $5,801,595. This trade represents a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be given a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.72%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio (DPR) is presently 21.27%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.